Abstract
Objective
This study was conducted to describe a 10-year trend of the supplement from 2000 to 2009 and to evaluate age, gender and racial disparities using a national level health data.
Design
Cross-sectional observational study.
Setting and Participants
Data collected from patient visit records to stand-alone US ambulatory care clinics. Visits made by men and women who were 40 years of age and older were included (n=175,830).
Measurements
Overall prevalence of recorded calcium and vitamin D use for osteoporosis prevention and treatment, and annual visit rates were estimated by age, gender, race, insurance types, physician specialties, geographical regions, and metropolitan status using chi square test. Multivariate logistic regression was conducted to determine potential predictive factors for calcium and vitamin D supplements.
Results
An increase in yearly trend of calcium and vitamin D supplements was observed. The increase was proportional to patients’ age (p<0.05) and female gender was a strong predictor of calcium and vitamin D supplement (p<0.0001).Visits made by blacks were significantly less likely to be associated with the supplement (p<0.05). Visits associated with self-pay and Medicaid was less likely to be recorded with vitamin D (p<0.05) but not calcium supplements. Osteoporosis diagnosis was an independent predictor of calcium and vitamin D records (p<0.0001).
Conclusions
In spite of the observed increases in the trend of visits associated with calcium and vitamin D supplements, variability in the access to the medications was observed. More focused strategies targeting elderly, men, or black population are needed to maintain and improve adequate calcium and vitamin D supplements.
Similar content being viewed by others
References
National Osteoporosis Foundation (NOF): What is osteoporosis? Available at http://nof.org/articles/7, Accessed December 26, 2013.
National Osteoporosis Foundation. Clinician’s Guide to Prevention and Treatment of Osteoporosis. Washington, DC: National Osteoporosis Foundation;2013
Institute of Medicine (IOM), Food and Nutrition Board. Dietary Reference Intakes for Calcium and Vitamin D. Washington, DC: National Academy Press, 2011.
Holick MF. Vitamin D deficiency. New Engl J Med, 2007: 357, 266–281.
Dawson-Hughes B, Harris SS, Krall EA, et al. Effect of calcium and vitamin D supplement on bone density in men and women 65 years of age or older. New Engl J Med, 1997:337, 670–676.
Holick MF. Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr, 2004:80, 1678S–1688S.
Calvo MS, Whiting SJ, Barton CN. Vitamin D intake: a global perspective of current status. J Nutr, 2005:135, 310–316.
Littlejohns TJ, Henley WE, Lang IA, et al. Vitamin D and the risk of dementia and Alzheimer disease. Neurology, 2014;83(10), 920–928.
Bailey RL, Dodd KW, Goldman JA, et al. Estimation of total usual calcium and vitamin D intakes in the United States. J Nutr, 2010:140, 817–822.
Ma J, Johns RA, Stafford RS. Americans are not meeting current calcium recommendations. Am J Clin Nutr, 2007:85, 1361–1366.
Moore CE, Murphy MM, Holick MF. Vitamin D intakes by children and adults in the United States differ among ethnic groups. J Nutr, 2005:135, 2478–2485.
National Center for Health Statistics. National Ambulatory Medical Care Survey. Available at http://www.cdc.gov/nchs/ahcd/about_ahcd.htm#NAMCS, accessed on October 28, 2013.
National Center for Health Statistics. National Ambulatory Medical Care Survey, 2006: Public use micro-data file documentation; data and documentation produced by the National Center for Health Statistics. Hyattsville, MD 2009.
National Institute of Health (NIH). Office of Dietary Supplements: vitamin and mineral supplement fact sheets. Available at http://dietarysupplements.info.nih.gov/Health_Information/Vitamin_and_Mineral_Supplement_Fact_Sheets.aspx. Accessed on October 26, 2012.
Watts NB, Bilezikian JP, Camacho PM, et al. American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the Diagnosis and Treatment of Postmenopausal Osteoporosis. Endocrinol Pract, 2010:16 (suppl 3), 1–37.
Di Daniele N, Carbonelli MG, Candeloro N. Effect of supplement of calcium and vitamin D on bone mineral density and bone mineral content in peri- and post-menopause women; a double blind, randomized, controlled trial. Pharmacological Research, 2004:50, 637–641.
Holick MF, Siris ES, Binkley N, Beard MK, et al. Prevalence of vitamin D inadequacy among postmenopausal North American women receiving osteoporosis therapy. J Clin Endocrinol Metab, 2005; 90: 3215–3224.
Lips P. Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocrine Reviews, 2001: 22: 477–501.
Boonen S, Vanderschueren D, Haentjens P, et al. Calcium and vitamin D in the prevention and treatment of osteoporosis- a clinical update. J Int Med, 2006; 259: 539–552.
Chapuy MC, Pamphile R, Paris E, et al. Combined calcium and vitamin D3 supplement in elderly women: confirmation of reversal of secondary hyperparathyroidism and hip fracture risk: The Decalyos II Study. Osteoporos Int, 2002; 13:257–264.
Jackson RD, La Croix AZ, Gass M, et al. Calcium plus vitamin D supplement and the risk of fractures. New Engl J Med, 2006; 354 (7): 669–683.
Porthouse J, Cockayne S, King C, et al. Randomised controlled trial of calcium and supplement with cholecalciferol (vitamin D3) for prevention of fractures in primary care. BMJ, 2005;330: 1–6
Wishart JM, Need AG, Horowitz M, et al. Effect of age on bone density and bone turnover in men. Clin Endocrinol, 1995:42(2), 141–146.
Basile M, Ciardi L, Crespi I, et al. Assessing serum concentrations of 25-hydroxy-vitamin D in north-western Italy. J Frailty Aging, 2013:2(4), 174–178.
Kiebzak GM, Beinart GA, Perser KP, et al. Under treatment of osteoporosis in men with hip fracture. Arch Intern Med, 2002:162, 2217–2222.
Cree M, Soskolne CL, Belseck E, et al. Mortality and institutionalization following hip fracture. J Am Geriatr Soc, 2000:48, 283–288.
Klibanski A, Adams-Campbell L, Bassford T, et al. Osteoporosis prevention, diagnosis, and therapy. NIH Consensus Statement. JAMA, 2001:285, 785–795.
Barrett-Connor E, Siris ES, Wehren LE, et al. Osteoporosis and fracture risk in women of different ethnic groups. J Bone Miner Res, 2005:20, 185–194.
Looker AC, Melton LJ 3rd, Harris TB, et al. Prevalence and trends in low femur bone density among older US adults: NHANES 2005–2006 compared with NHANES III. J Bone Miner Res, 2010:25, 64–71.
Geller SE and Derman R. Knowledge, beliefs, and risk factors for osteoporosis among African American and Hispanic Women. J Natl Med Assoc, 2001:93, 13–21.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lee, S., Teschemaker, A.R., Daniel, M. et al. Calcium and vitamin D use among older adults in U.S.: Results from national survey. J Nutr Health Aging 20, 300–305 (2016). https://doi.org/10.1007/s12603-015-0614-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12603-015-0614-9